Audiograms and hearing loss before and after cisplatin-based chemotherapy (CBCT) in testicular cancer survivors (TCS).

被引：0
|
作者：
Haugnes, Hege Sagstuen
Stenklev, Niels Christian
Brydoy, Marianne
Wilsgaard, Tom
Laukli, Einar
Fossa, Sophie D.
机构：
[1] Univ Hosp North Norway, Tromso, Norway
[2] Univ Hosp North Norway, Dept Ear Nose & Throat, Tromso, Norway
[3] Haukeland Hosp, N-5021 Bergen, Norway
[4] Univ Tromsoe, Inst Community Med, Tromso, Norway
[5] Univ Oslo, Oslo Univ Hosp, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e16047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16047
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
    Haugnes, Hege S.
    Stenklev, Niels Christian
    Brydoy, Marianne
    Dahl, Olav
    Wilsgaard, Tom
    Laukli, Einar
    Fossa, Sophie D.
    ACTA ONCOLOGICA, 2018, 57 (08) : 1075 - 1083
  • [2] Hearing loss after cisplatin-based chemotherapy (CBCT) in testicular cancer survivors (TCSs): less than previously described
    Fossa, S. D.
    Haugnes, H.
    Laukli, E.
    Brydoy, M.
    Stenklev, N. C.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S172 - S173
  • [3] Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
    Garcia, Sara L.
    Lauritsen, Jakob
    Christiansen, Bernadette K.
    Hansen, Ida F.
    Bandak, Mikkel
    Dalgaard, Marlene D.
    Daugaard, Gedske
    Gupta, Ramneek
    CANCERS, 2023, 15 (15)
  • [4] Increased risk of non-germ cell second cancer (SC) after cisplatin-based chemotherapy (CBCT) in 1-year testicular cancer (TC) survivors (TCS)
    Hellesnes, R.
    Kvammen, O.
    Bremnes, R. M.
    Karlsdottir, A.
    Myklebust, T. A.
    Negaard, H.
    Tandstad, T.
    Wilsgaard, T.
    Fossa, S. D.
    Haugnes, H. S.
    ANNALS OF ONCOLOGY, 2018, 29 : 324 - 324
  • [5] Comprehensive characterization of cisplatin-related hearing loss in US and Canadian Testicular Cancer Survivors (TCS).
    Wheeler, Heather E.
    Travis, Lois B.
    Budnick, Amy
    Feldman, Darren Richard
    Einhorn, Lawrence H.
    Hamilton, Robert James
    Vaughn, David J.
    Beard, Clair
    Fung, Chunkit
    Johnson, Eileen
    Moore, Malcolm J.
    Sahasrabudhe, Deepak M.
    Fossa, Sophie D.
    Sesso, Howard D.
    Dolan, M. Eileen
    Frisina, Robert D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Regarding the effect of cisplatin-based chemotherapy on hearing loss in children with cancer
    Xiang, Li
    Liu, Ye
    Liu, Jinlin
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (04)
  • [7] Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy
    Wibmer, Andreas G.
    Dinh, Paul C., Jr.
    Travis, Lois B.
    Chen, Carol
    Bromberg, Maria
    Zheng, Junting
    Capanu, Marinela
    Sesso, Howard D.
    Feldman, Darren R.
    Vargas, Hebert Alberto
    JNCI CANCER SPECTRUM, 2022, 6 (04)
  • [8] RETINAL TOXICITY AFTER CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER
    Gild, Philipp
    Vetterlein, Malte W.
    Dieckmann, Klaus-Peter
    Matthies, Cord
    Wagner, Walter
    Ludwig, Tim A.
    Meyer, Christian P.
    Soave, Armin
    Dulz, Simon
    Asselborn, Niels H.
    Oechsle, Karin
    Bokemeyer, Carsten
    Becker, Andreas
    Fisch, Margit
    Hartmann, Michael
    Chun, Felix K. H.
    Kluth, Luis A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1085 - E1085
  • [9] ACUTE CEREBROVASCULAR EVENT AFTER CISPLATIN-BASED CHEMOTHERAPY FOR TESTICULAR CANCER
    GERL, A
    CLEMM, C
    WILMANNS, W
    LANCET, 1991, 338 (8763): : 385 - 386
  • [10] Adverse health outcomes (AHO) after modern cisplatin-based chemotherapy (CHEM) compared to surgery-only: A study of 503 testicular cancer survivors (TCS).
    Adra, Nabil
    Cary, Clint
    Althouse, Sandra K.
    Monahan, Patrick O.
    Norton, Kelli
    Cook, Ryan
    Einhorn, Lawrence
    Travis, Lois B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345